Donnie Yance is an internationally known master herbalist and nutritionist. He is the author of the book, "Herbal Medicine, Healing and Cancer" and "Adaptogens in Medical Herbalism"
Omicron and the Vaccine Conundrum With record levels of Covid cases at an all-time high since the onset of the pandemic due to the latest highly transmissible Omicron variant[1] ,people across the globe are increasingly fed up with ineffective methods to control the transmission by lockdowns, mandates and inoculating the planet. As we head into …
Vaccines No Match for Omicron and a Look at COVID-19 in Africa We’ve been living with COVID-19 now for more than two years, and questions continue to arise about the best approach for prevention and treatment. I have never been asked about anything as much as the COVID-19 vaccines and never have I seen so …
Continue reading “Vaccines No Match for Omicron and a Look at COVID-19 in Africa”
Although Omicron is now 73% of all new cases in the US[1], I don’t feel we need to press the panic button. I have some hypotheses on the emergence of the Omicron variant that could put the brakes on the doom and gloom scenario we are all being fed. According to a study published on …
Please refer to the original post here: (Ivermectin as a Prophylactic and Treatment for COVID-19) Because of flawed information flowing in on the efficacy or inefficiency of ivermectin, I have added some further research to this blog. Please refer to the original blog here for more details: BBC, Science Wire, and several other media outlets …
Having effective therapeutics is going to be increasingly important when it comes to confronting Covid-19 and the evolution of new variants. First detected in Japan, the R1 variant is the newest strain of COVID-19 that contains “multiple spike protein mutations”, that could enable it to bypass the antibody protection present in those who are fully vaccinated. …
Continue reading “Ivermectin as a Prophylactic and Treatment for COVID-19”
Given the ongoing discord within the scientific community regarding the short-term and long-term efficacy and safety of the different types of anti-SARS-CoV-2 vaccines, their experimental nature, and the availability of other therapeutic approaches,[1] such information should be universal and should be provided to every potential vaccine recipient. The safety and tolerance of COVID-19 vaccines must be …
Continue reading “Weighing the Risk-to-Benefit Ratio of COVID-19 Vaccines”